MSC1936369B
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MSC1936369B, covering 2016-04-01 to 2018-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Trial of MSC1936369B in Subjects With Solid Tumors [Phase 1]